Akbar Seddigh

Presidente presso Blekinge Tekniska Högskola

81 anni

Health Technology

Finance

Producer Manufacturing

Profilo

Akbar Seddigh is currently the Chairman at Blekinge Tekniska Högskola.
Previously, he served as the Chairman at Elekta AB from 1998 to 2013.
He also held Chairman positions at A+ Science Holding AB, Hedson Technologies International AB, and Innovationsbron AB.
Additionally, he served as a Director at Light Sciences Oncology, Inc., Athera Biotechnologies AB, Biolight International AB, Affärsstrategerna AB, Samba Sensors AB, and SwedenBIO Service AB.

Posizioni attive di Akbar Seddigh

Società	Posizione	Inizio
Blekinge Tekniska Högskola	Presidente	05/05/2010

Tutte le posizioni attive di Akbar Seddigh

Precedenti posizioni note di Akbar Seddigh

Società	Posizione	Fine
ELEKTA AB	Presidente	03/09/2013
Innovationsbron AB Innovationsbron AB Investment ManagersFinance Innovationsbron AB, established in 2005, is an agency set up and majority-owned by the Government of Sweden. Claes de Neergaard was mandated by the Ministry of Industry to develop innovative financing to commercially develop research-related business ideas. Headquartered in Stockholm, Innovationsbron also has four regional offices in Umea, Uppsala, Gothenburg and Lund. Innovationsbron operates a nationwide network of business incubators as well as a regional program of incubators which support scientists, innovators and entrepreneurs.	Presidente	31/12/2012
Biolight International AB	Direttore/Membro del Consiglio	22/03/2010
Athera Biotechnologies AB Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden.	Direttore/Membro del Consiglio	-
A+ Science Holding AB A+ Science Holding AB MiscellaneousMiscellaneous A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden.	Presidente	-

Vedi nel dettaglio l'esperienza di Akbar Seddigh

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Akbar Seddigh

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ELEKTA AB	Health Technology

Aziende private	9
Hedson Technologies International AB Hedson Technologies International AB Industrial MachineryProducer Manufacturing Hedson Technologies International AB sells equipment and supplies for the car and tires, through its subsidiary. It engages in the manufacture and trade of cleaning, drying, and lifting equipment for the automotive industry. The company was founded on August 26, 1992 and is headquartered in Arlöv, Sweden.	Producer Manufacturing
Innovationsbron AB Innovationsbron AB Investment ManagersFinance Innovationsbron AB, established in 2005, is an agency set up and majority-owned by the Government of Sweden. Claes de Neergaard was mandated by the Ministry of Industry to develop innovative financing to commercially develop research-related business ideas. Headquartered in Stockholm, Innovationsbron also has four regional offices in Umea, Uppsala, Gothenburg and Lund. Innovationsbron operates a nationwide network of business incubators as well as a regional program of incubators which support scientists, innovators and entrepreneurs.	Finance
Samba Sensors AB Samba Sensors AB Electronic Equipment/InstrumentsElectronic Technology Samba Sensors AB is a developer and manufacturer of advanced fiber-optic pressure transducers for measurements of blood, intracranial, intradiscal, tissue, urological, and respiratory pressure. The company was founded by Olof Engström in 1991 and is headquartered in Gothenburg, Sweden.	Electronic Technology
Light Sciences Oncology, Inc. Light Sciences Oncology, Inc. Pharmaceuticals: MajorHealth Technology Light Sciences Oncology, Inc. operates as a pharmaceutical company. It develops Aptocine for the treatment of solid tumors as well as other indications such as benign prostatic hyperplasia. The company was founded in 1994 and is headquartered in Bellevue, WA.	Health Technology
Affärsstrategerna AB Affärsstrategerna AB Financial ConglomeratesFinance Affärsstrategerna AB is a venture capital company that invests in projects and companies that are in early stages. The firm invests in life science, information technology, wireless and energy sectors. Affärsstrategerna was founded in 1988 by Claes-Göran Fridh and is headquartered in Stockholm, Sweden.	Finance
SwedenBIO Service AB SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden.	Commercial Services
Biolight International AB	Health Technology
A+ Science Holding AB A+ Science Holding AB MiscellaneousMiscellaneous A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden.	Miscellaneous
Athera Biotechnologies AB Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden.	Health Technology